3-hydroxyephedrine has been researched along with Diabetic Neuropathies in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kirkwood, I; Larkin, D; Marinescu, V; Pop-Busui, R; Raffel, DM; Schmid, H; Schroeder, J; Stevens, MJ; Yamada, E | 1 |
Allman, KC; Greene, DA; Hutchins, GD; Schwaiger, M; Stevens, MJ; Wieland, DM; Wolfe, ER | 1 |
Allman, KC; Dayanikli, F; Ficaro, E; Pfeifer, MA; Raffel, DM; Sandford, T; Schwaiger, M; Stevens, MJ; Wieland, DM | 1 |
Allman, KC; Raffel, DM; Schwaiger, M; Stevens, MJ; Wieland, DM | 1 |
Cao, X; Forman, LA; Schmid, H; Sherman, PS; Stevens, MJ | 1 |
Stevens, MJ | 1 |
1 review(s) available for 3-hydroxyephedrine and Diabetic Neuropathies
Article | Year |
---|---|
New imaging techniques for cardiovascular autonomic neuropathy: a window on the heart.
Topics: 3-Iodobenzylguanidine; Animals; Carbon Radioisotopes; Cardiovascular Diseases; Diabetic Neuropathies; Ephedrine; Heart; Heart Conduction System; Humans; Models, Biological; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
5 other study(ies) available for 3-hydroxyephedrine and Diabetic Neuropathies
Article | Year |
---|---|
Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction.
Topics: Adenosine; Adult; Autonomic Nervous System Diseases; C-Reactive Protein; Carbon Radioisotopes; Contrast Media; Coronary Circulation; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Diastole; Ephedrine; Female; Heart; Heart Conduction System; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Oxidative Stress; Vasoconstriction; Ventricular Dysfunction, Left; von Willebrand Factor | 2004 |
Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Blood Flow Velocity; Carbon Radioisotopes; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Ephedrine; Female; Heart Diseases; Humans; Male; Middle Aged; Sensitivity and Specificity; Severity of Illness Index; Sympathetic Nervous System; Tomography, Emission-Computed | 1993 |
Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk.
Topics: Adult; Analysis of Variance; Carbon Radioisotopes; Denervation; Diabetic Neuropathies; Ephedrine; Female; Heart; Heart Rate; Heart Ventricles; Humans; Image Processing, Computer-Assisted; Male; Neurons; Reference Values; Sympathetic Nervous System; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1998 |
Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography.
Topics: Adult; Autonomic Nervous System Diseases; Carbon Radioisotopes; Denervation; Diabetic Neuropathies; Ephedrine; Female; Heart; Humans; Male; Middle Aged; Reflex; Reproducibility of Results; Sympathetic Nervous System; Tomography, Emission-Computed | 1999 |
Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes.
Topics: Animals; Blood Glucose; Body Weight; Carbon Radioisotopes; Denervation; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ephedrine; Heart; Male; Myocardium; Nerve Growth Factors; Norepinephrine; Radionuclide Imaging; Rats; Rats, Wistar; Sympathetic Nervous System; Tissue Distribution; Ventricular Function | 1999 |